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analysis. These corresponded to the reports collected during the 3 years after the complete implementation of the PACS (post-PACS years 1, 2 and 3). These intervention groups were compared with the control group, in which the reports were collected during the year before the implementation of the PACS (pre-PACS year). An additional group was considered in which PACS and hard-copy images co-existed. This corresponding to the year in which PACS was implemented (PACS transition year). The study was performed at a single centre. The period of follow-up appears to have been until the results of the initial examinations were obtained, in cases where no incidental findings were found or, for those cases with an incidental finding, until the results of further examinations were obtained.
Analysis of effectiveness
The primary health outcomes considered at analysis were: the total incidental findings and the number of patients associated with them; the frequency and type of incidental finding per year; the number of follow-up studies recommended; the number of ultrasonography examinations required; and the number of malignancies and occult metastatic disease detected.
The groups were not shown to be comparable at analysis.
Effectiveness results
A total of 202 incidental findings among 183 patients were found throughout the whole study period, although only 83 had clinical charts available for review.
The numbers of incidental findings were 19 during the pre-PACS year, 31 during the PACS transition year, 53 during post-PACS year 1, 49 during post-PACS year 2, and 50 during post-PACS year 3.
The increase in the number of incidental findings was significant for each year after PACS implementation, (p<0.001), but not for the transition year, (p=0.055).
The most frequent incidental findings were renal, uterine, adnexal, hepatic, lymph node and pulmonary abnormalities.
When compared with the pre-PACS year (with 5 follow-up studies recommended), the total number of follow-up studies recommended increased significantly after the introduction of PACS. Fifteen studies were recommended during the transition year, (p=0.02), 32 during post-PACS year 1, (p<0.001), 22 during post-PACS year 2, (p=0.001), and 18 during post-PACS year 3, (p=0.005).
The number of ultrasonography examinations increased from 2 during the pre-PACS year to 11 during the transition year, 27 during post-PACT year 1, 17 during post-PACT year 2, and 14 during post-PACT year 3.
Authors' conclusions
The introduction of a picture archiving and communication system (PACS) for lumbar spinal magnetic resonance imaging (MRI) appears to have been associated with an increase in the number of incidental findings (most commonly, renal, gynaecologic and hepatic abnormalities) and follow-up studies recommended. Although costs may increase as a result of additional examinations, there is the advantage that some cases of occult malignant disease would be identified.
CRD COMMENTARY -Selection of comparators
The use of hard-copy images was considered to be the comparator because it was the current practice in the authors' setting before the PACS was implemented. You should consider whether this is a widely used health technology in your own setting.
Validity of estimate of measure of effectiveness
This was a retrospective comparative study with historical controls. It may have been appropriate given the data available to perform the study, but it is subject to considerable bias, such as patient selection bias (it could not assure that the patients' characteristics were similar across groups) or environmental differences due to differences across time. As the authors stated, reports instead of images were reviewed, which may have resulted in less incidental findings being identified. In addition, the follow-up results for incidental findings were not available for all of the patients. There may have been variability, both in the interpretation of the incidental findings (several radiologists interpreted the images) and in medical practice (the requirement for further follow-up procedures). The study sample may not have been representative of the study population since patients from only one institution were considered for the effectiveness analysis. Therefore, the clinical study may lack both internal and external validity.
Validity of estimate of measure of benefit
The summary measure of benefit used in the economic analysis (i.e. the total number of cases of occult malignancies identified with PACS outside the area of interest) was obtained directly from the effectiveness analysis. The implicit justification appears to have been that the use of PACS images allows the interpretation of incidental findings outside the region of interest. Other measures of benefit (e.g. the number of quality-adjusted life-years gained) would allow the results to compared with those from different interventions, although they would be difficult to estimate in this study.
Validity of estimate of costs
Not all the costs relevant to the perspective adopted were considered in the economic analysis. This exclusion is likely to have affected the authors' conclusions. The authors stated that the costs associated with the PACS may have been underestimated. No statistical or sensitivity analyses of the costs were reported. Some resource quantities were given separately, but not the associated unit costs. Therefore, there is considerably uncertainty surrounding the cost estimation. In addition, it would be difficult to perform appropriate relation exercises in other settings. The price year was given. Discounting was not performed since the follow-up period appears to have been less than 2 years.
Other issues
The authors made appropriate comparisons of their findings with those from other studies. These consistently showed that the productivity of the radiology department may increase by using a PACS because of the reduction in the time required for examination, an improvement in detection of findings, and a potential increase in cost-effectiveness. The fact that patients from a single institution were considered for the effectiveness analysis may, as the authors acknowledged, limit the generalisability of the results to other settings. The cost-effectiveness ratio calculated was meaningless for decision-making purposes, as it divided the combined costs from both intervention periods by the combined effects from both periods. The appropriate analysis would have been to divide the difference in costs between the interventions by the difference in effects between the interventions. 
Implications of the study

